Veeva Systems (VEEV) vs peers in numbers

VEEV and 9 peers, year by year

The 9 Health care companies closest to VEEV in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

5 years 10 years Download CSV

Choose the peers

Each company's latest fiscal year
Company	Year	Revenue	Sales growth	Gross margin	Operating margin	Net margin	FCF margin	Return on equity	Debt / equity
VEEV Veeva Systems	FY2026	$3.2B	+16.3%	75.5%	28.7%	28.4%	-	12.6%	-
WST West Pharmaceutical Services	FY2025	$3.1B	+6.3%	35.9%	19.0%	16.1%	15.3%	15.5%	0.06
PODD Insulet Corporation	FY2025	$2.7B	+30.7%	71.6%	17.5%	9.1%	13.9%	16.3%	0.63
CRL Charles River Laboratories	FY2025	$4.0B	−0.9%	-	0.6%	−3.6%	12.9%	−4.6%	0.68
RVTY Revvity	FY2025	$2.9B	+3.7%	-	12.5%	8.4%	17.8%	3.3%	0.44
ALGN Align Technology	FY2025	$4.0B	+0.9%	67.2%	13.5%	10.2%	12.2%	10.1%	-
MTD Mettler Toledo	FY2025	$4.0B	+4.0%	59.4%	-	21.6%	21.1%	n/m	n/m
COO Cooper Companies	FY2025	$4.1B	+5.1%	65.5%	16.7%	9.2%	10.6%	4.6%	0.30
MRNA Moderna	FY2025	$1.9B	−39.9%	-	−158.1%	−145.2%	−106.2%	−32.6%	0.07
ILMN Illumina, Inc.	FY2025	$4.3B	−0.7%	66.1%	18.6%	19.6%	21.4%	31.2%	0.73

Revenuepeer median $4.0B

Sales growthpeer median +3.7%

Gross marginpeer median 65.8%

Operating marginpeer median 15.1%

Net marginpeer median 9.2%

FCF marginpeer median 13.9%

Return on equitypeer median 7.3%

Debt / equitypeer median 0.44

ILMN 0.73
CRL 0.68
PODD 0.63
RVTY 0.44
COO 0.30
MRNA 0.07
WST 0.06
VEEV -
ALGN -
MTD n/m

RevenueSales growthGross marginOperating marginNet marginFree cash flowFCF marginReturn on equityDebt / equityEPS (diluted)

Revenue, FY2016 to FY2026

Revenue as reported in the 10-K.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2023	FY2024	FY2025	FY2026
VEEV Jan	$409.2M	$550.5M	$690.6M	$862.2M	$1.1B	$1.9B	$2.2B	$2.4B	$2.7B	$3.2B
WST Dec	$1.5B	$1.6B	$1.7B	$1.8B	$2.1B	$2.8B	$2.9B	$2.9B	$3.1B	-
PODD Dec	$367.0M	$463.8M	$563.8M	$738.2M	$904.4M	$1.1B	$1.7B	$2.1B	$2.7B	-
CRL Dec	$1.7B	$1.9B	$2.3B	$2.6B	$2.9B	$3.5B	$4.1B	$4.0B	$4.0B	-
RVTY Dec	$2.1B	$2.3B	$2.8B	$2.9B	$3.8B	$3.8B	$2.8B	$2.8B	$2.9B	-
ALGN Dec	$1.1B	$1.5B	$2.0B	$2.4B	$2.5B	$4.0B	$3.9B	$4.0B	$4.0B	-
MTD Dec	$2.5B	$2.7B	$2.9B	$3.0B	$3.1B	$3.7B	$3.8B	$3.9B	$4.0B	-
COO Oct	$2.0B	$2.1B	$2.5B	$2.7B	$2.4B	$2.9B	$3.6B	$3.9B	$4.1B	-
MRNA Dec	$108.4M	$205.8M	$135.1M	$60.2M	$803.0M	$18.5B	$6.8B	$3.2B	$1.9B	-
ILMN Dec	$2.4B	$2.8B	$3.3B	$3.5B	$3.2B	$4.5B	$4.5B	$4.4B	$4.3B	-
Peer median	$1.7B	$1.9B	$2.3B	$2.6B	$2.5B	$3.7B	$3.8B	$3.9B	$4.0B	-

Sales growth, FY2016 to FY2026

Revenue against the fiscal year before.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2023	FY2024	FY2025	FY2026
VEEV Jan	-	+32.9%	+25.4%	+24.9%	+28.1%	+26.3%	+16.4%	+9.7%	+16.2%	+16.3%
WST Dec	+7.8%	+6.0%	+7.4%	+7.1%	+16.7%	+31.9%	+2.2%	−1.9%	+6.3%	-
PODD Dec	+39.1%	+26.4%	+21.6%	+30.9%	+22.5%	+15.1%	+30.0%	+22.1%	+30.7%	-
CRL Dec	+23.3%	+10.5%	+22.0%	+15.7%	+11.5%	+21.1%	+3.9%	−1.9%	−0.9%	-
RVTY Dec	+0.5%	+6.7%	+23.1%	+3.8%	+31.2%	+43.7%	−16.9%	+0.2%	+3.7%	-
ALGN Dec	+27.7%	+36.4%	+33.5%	+22.4%	+2.7%	+59.9%	+3.4%	+3.5%	+0.9%	-
MTD Dec	+4.7%	+8.6%	+7.7%	+2.5%	+2.5%	+20.5%	−3.4%	+2.2%	+4.0%	-
COO Oct	+9.4%	+8.8%	+18.4%	+4.8%	−8.4%	+20.2%	+8.6%	+8.4%	+5.1%	-
MRNA Dec	-	+89.9%	−34.4%	−55.4%	n/m	n/m	−64.4%	−52.7%	−39.9%	-
ILMN Dec	+8.0%	+14.8%	+21.1%	+6.3%	−8.6%	+39.7%	−1.7%	−2.9%	−0.7%	-
Peer median	+8.7%	+10.5%	+21.1%	+6.3%	+7.1%	+26.5%	+2.2%	+0.2%	+3.7%	-

Gross margin, FY2016 to FY2026

Gross profit / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2023	FY2024	FY2025	FY2026
VEEV Jan	65.2%	68.5%	69.4%	71.6%	72.5%	72.8%	71.7%	71.3%	74.5%	75.5%
WST Dec	33.2%	32.1%	31.8%	32.9%	35.8%	41.5%	38.3%	34.5%	35.9%	-
PODD Dec	57.5%	59.8%	65.7%	65.1%	64.4%	68.4%	68.3%	69.8%	71.6%	-
CRL Dec	-	-	-	-	-	-	-	-	-	-
RVTY Dec	47.9%	47.6%	48.3%	48.4%	55.8%	63.6%	-	-	-	-
ALGN Dec	75.5%	75.8%	73.6%	72.5%	71.3%	74.3%	70.1%	70.0%	67.2%	-
MTD Dec	57.3%	57.8%	57.4%	57.9%	58.4%	58.4%	59.2%	60.1%	59.4%	-
COO Oct	59.6%	63.9%	64.4%	66.2%	63.1%	66.9%	65.6%	66.6%	65.5%	-
MRNA Dec	-	-	-	-	-	-	-	-	-	-
ILMN Dec	69.5%	66.4%	69.0%	69.6%	68.0%	69.7%	60.9%	65.4%	66.1%	-
Peer median	57.5%	59.8%	64.4%	65.1%	63.1%	66.9%	63.3%	66.0%	65.8%	-

Operating margin, FY2016 to FY2026

Operating income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2023	FY2024	FY2025	FY2026
VEEV Jan	19.2%	21.9%	22.9%	25.8%	25.9%	27.3%	21.3%	18.2%	25.2%	28.7%
WST Dec	12.9%	14.1%	14.0%	16.1%	19.0%	26.6%	22.9%	19.7%	19.0%	-
PODD Dec	−2.9%	−1.6%	4.9%	6.8%	5.7%	11.5%	13.0%	14.9%	17.5%	-
CRL Dec	14.1%	15.5%	14.6%	13.4%	14.8%	16.7%	14.9%	5.6%	0.6%	-
RVTY Dec	13.9%	13.1%	11.7%	12.6%	22.9%	32.9%	10.9%	12.6%	12.5%	-
ALGN Dec	23.1%	24.0%	23.7%	22.5%	15.7%	24.7%	16.7%	15.2%	13.5%	-
MTD Dec	-	-	-	-	-	-	-	-	-	-
COO Oct	16.5%	20.1%	15.9%	20.6%	12.8%	17.3%	14.8%	18.1%	16.7%	-
MRNA Dec	−206.4%	−130.9%	−306.0%	−906.8%	−95.0%	72.0%	−61.9%	−121.9%	−158.1%	-
ILMN Dec	24.5%	22.0%	26.5%	27.8%	17.9%	−2.7%	−23.7%	−19.1%	18.6%	-
Peer median	14.0%	14.8%	14.3%	14.8%	15.2%	21.0%	13.9%	13.7%	15.1%	-

Net margin, FY2016 to FY2026

Net income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2023	FY2024	FY2025	FY2026
VEEV Jan	13.3%	14.1%	21.9%	26.7%	27.3%	23.1%	22.6%	22.2%	26.0%	28.4%
WST Dec	9.5%	9.4%	12.0%	13.1%	16.1%	23.4%	20.1%	17.0%	16.1%	-
PODD Dec	−7.9%	−5.8%	0.6%	1.6%	0.8%	1.5%	12.2%	20.2%	9.1%	-
CRL Dec	9.2%	6.6%	10.0%	9.6%	12.5%	11.0%	11.5%	0.5%	−3.6%	-
RVTY Dec	11.1%	13.0%	8.6%	7.9%	19.2%	24.6%	25.2%	9.8%	8.4%	-
ALGN Dec	17.6%	15.7%	20.4%	18.4%	71.8%	19.5%	11.5%	10.5%	10.2%	-
MTD Dec	15.3%	13.8%	17.5%	18.6%	19.5%	20.7%	20.8%	22.3%	21.6%	-
COO Oct	13.9%	17.4%	5.5%	17.6%	9.8%	100.8%	8.2%	10.1%	9.2%	-
MRNA Dec	−199.5%	−124.3%	−284.8%	−853.7%	−93.0%	66.1%	−68.8%	−110.0%	−145.2%	-
ILMN Dec	19.3%	26.4%	24.8%	28.3%	20.3%	16.8%	−25.8%	−28.0%	19.6%	-
Peer median	11.1%	13.0%	10.0%	13.1%	16.1%	20.7%	11.5%	10.1%	9.2%	-

Free cash flow, FY2016 to FY2026

Cash from operations minus capital spending.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2023	FY2024	FY2025	FY2026
VEEV Jan	$59.0M	$137.1M	$223.8M	$302.4M	$434.3M	-	-	-	-	-
WST Dec	$49.2M	$132.5M	$183.9M	$240.8M	$298.1M	$330.6M	$414.5M	$276.4M	$468.9M	-
PODD Dec	−$6.2M	−$32.5M	−$121.5M	−$65.3M	−$45.0M	−$180.0M	$70.1M	$305.3M	$377.7M	-
CRL Dec	$261.6M	$235.6M	$301.1M	$340.4M	$380.0M	$532.0M	$365.4M	$501.6M	$518.5M	-
RVTY Dec	$318.9M	$249.4M	$217.8M	$287.1M	$828.5M	$1.3B	$9.9M	$541.7M	$509.4M	-
ALGN Dec	$177.1M	$242.8M	$331.4M	$597.6M	$507.3M	$771.4M	$608.1M	$622.7M	$490.8M	-
MTD Dec	$336.8M	$388.9M	$422.3M	$506.1M	$632.2M	$801.2M	$860.6M	$864.4M	$848.6M	-
COO Oct	$357.0M	$466.4M	$475.3M	$421.1M	$176.2M	$524.2M	$215.0M	$288.1M	$433.7M	-
MRNA Dec	$33.6M	−$389.9M	−$436.6M	−$491.0M	$2.0B	$13.3B	−$3.8B	−$4.1B	−$2.1B	-
ILMN Dec	$519.0M	$565.0M	$846.0M	$842.0M	$891.0M	$337.0M	$283.0M	$709.0M	$931.0M	-
Peer median	$261.6M	$242.8M	$301.1M	$340.4M	$507.3M	$532.0M	$283.0M	$501.6M	$490.8M	-

FCF margin, FY2016 to FY2026

Free cash flow / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2023	FY2024	FY2025	FY2026
VEEV Jan	14.4%	24.9%	32.4%	35.1%	39.3%	-	-	-	-	-
WST Dec	3.3%	8.3%	10.7%	13.1%	13.9%	11.7%	14.1%	9.6%	15.3%	-
PODD Dec	−1.7%	−7.0%	−21.6%	−8.8%	−5.0%	−16.4%	4.1%	14.7%	13.9%	-
CRL Dec	15.6%	12.7%	13.3%	13.0%	13.0%	15.0%	8.8%	12.4%	12.9%	-
RVTY Dec	15.1%	11.0%	7.8%	10.0%	21.9%	34.6%	0.4%	19.7%	17.8%	-
ALGN Dec	16.4%	16.5%	16.9%	24.8%	20.5%	19.5%	15.7%	15.6%	12.2%	-
MTD Dec	13.4%	14.3%	14.4%	16.8%	20.5%	21.6%	22.7%	22.3%	21.1%	-
COO Oct	18.2%	21.8%	18.8%	15.9%	7.2%	17.9%	6.0%	7.4%	10.6%	-
MRNA Dec	31.0%	−189.4%	−323.3%	−815.5%	244.0%	72.2%	−55.9%	−125.3%	−106.2%	-
ILMN Dec	21.6%	20.5%	25.4%	23.8%	27.5%	7.4%	6.3%	16.2%	21.4%	-
Peer median	15.6%	12.7%	13.3%	13.1%	20.5%	17.9%	6.3%	14.7%	13.9%	-

Return on equity, FY2016 to FY2026

Net income / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2023	FY2024	FY2025	FY2026
VEEV Jan	10.4%	11.4%	16.7%	18.6%	18.1%	14.7%	13.1%	11.3%	12.2%	12.6%
WST Dec	12.9%	11.8%	14.8%	15.4%	18.7%	28.3%	20.6%	18.4%	15.5%	-
PODD Dec	−45.8%	−16.9%	1.6%	15.3%	1.1%	3.0%	28.2%	34.5%	16.3%	-
CRL Dec	18.5%	11.8%	17.2%	15.4%	17.2%	15.4%	13.2%	0.6%	−4.6%	-
RVTY Dec	10.9%	11.7%	9.2%	8.1%	19.5%	13.2%	8.8%	3.5%	3.3%	-
ALGN Dec	19.0%	20.0%	31.9%	32.9%	54.9%	21.3%	12.3%	10.9%	10.1%	-
MTD Dec	88.4%	68.7%	86.9%	133.3%	n/m	n/m	n/m	n/m	n/m	-
COO Oct	10.2%	11.7%	4.2%	12.9%	6.2%	42.4%	3.9%	4.9%	4.6%	-
MRNA Dec	n/m	n/m	−25.1%	−43.7%	−29.2%	86.3%	−34.0%	−32.7%	−32.6%	-
ILMN Dec	21.1%	26.4%	22.0%	21.7%	14.0%	7.1%	−20.2%	−51.5%	31.2%	-
Peer median	15.7%	11.8%	14.8%	15.4%	15.6%	18.4%	10.5%	4.2%	7.3%	-

Debt / equity, FY2016 to FY2026

Total debt / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2023	FY2024	FY2025	FY2026
VEEV Jan	-	-	-	-	-	-	-	-	-	-
WST Dec	0.21	0.15	0.14	0.16	0.14	0.11	0.07	0.08	0.06	-
PODD Dec	5.27	3.57	2.79	11.70	1.75	2.29	1.93	1.14	0.63	-
CRL Dec	1.41	1.04	1.22	1.15	0.93	1.05	0.74	0.65	0.68	-
RVTY Dec	0.49	0.80	0.73	0.74	0.53	0.70	0.50	0.41	0.44	-
ALGN Dec	-	-	-	-	-	-	-	-	-	-
MTD Dec	2.06	1.79	1.75	3.07	4.72	9.81	n/m	n/m	n/m	-
COO Oct	0.57	0.37	0.61	0.50	0.47	0.21	0.34	0.32	0.30	-
MRNA Dec	-	-	-	-	-	-	-	0.00	0.07	-
ILMN Dec	0.48	0.43	0.22	0.25	0.25	0.09	0.26	0.84	0.73	-
Peer median	0.57	0.80	0.73	0.74	0.53	0.70	0.42	0.41	0.44	-

EPS (diluted), FY2016 to FY2026

Diluted earnings per share, on today's share count after splits.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2023	FY2024	FY2025	FY2026
VEEV Jan	$0.38	$0.53	$0.98	$1.47	$1.90	$2.63	$3.00	$3.22	$4.32	$5.44
WST Dec	$1.91	$1.99	$2.74	$3.21	$4.57	$8.67	$7.88	$6.69	$6.79	-
PODD Dec	−$0.48	−$0.46	$0.05	$0.19	$0.10	$0.24	$2.94	$5.78	$3.48	-
CRL Dec	$3.23	$2.54	$4.62	$5.07	$7.20	$7.60	$9.22	$0.20	−$2.91	-
RVTY Dec	$2.12	$2.64	$2.13	$2.04	$6.49	$8.08	$5.55	$2.20	$2.07	-
ALGN Dec	$2.33	$2.83	$4.92	$5.53	$22.41	$9.69	$5.81	$5.62	$5.65	-
MTD Dec	$14.22	$14.24	$19.88	$22.47	$24.91	$32.78	$35.90	$40.48	$42.05	-
COO Oct	$1.40	$1.88	$0.70	$2.33	$1.20	$14.79	$1.48	$1.96	$1.87	-
MRNA Dec	−$3.79	−$4.18	−$4.95	−$1.55	−$1.96	$28.29	−$12.33	−$9.28	−$7.26	-
ILMN Dec	$3.07	$4.92	$5.56	$6.74	$4.45	$5.04	−$7.34	−$7.69	$5.45	-
Peer median	$2.12	$2.54	$2.74	$3.21	$4.57	$8.67	$5.55	$2.20	$3.48	-

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out VEEV and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →

Work on VEEV in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/VEEV/export.csv") into a cell.

VEEVVeeva Systems